secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 76264 grounded facts newest August 31, 2026, 5:22 PM ET RSS · JSON

Showing 3951–4000 of 76264

Departed

Suketu Upadhyay

Director
VRTX · VERTEX PHARMACEUTICALS INC / MA
Filed
April 29, 2026, 7:59 PM ET
Suketu Upadhyay informed the board of directors (the "Board") of Vertex Pharmaceuticals Incorporated (the "Company") of his decision not to stand for re-election as a director of the Company at the Company’s 2026 annual meeting of shareholders (the "2026 Annual Meeting").
Appointed

Grant T. Burcham

Class III director
HWBK · HAWTHORN BANCSHARES, INC.
Effective
2026-04-29
Filed
April 29, 2026, 7:59 PM ET
the board of directors of each of the Company and Hawthorn Bank increased their respective sizes by one member, and appointed Grant T. Burcham to serve on both the Company's and Hawthorn Bank's board of directors to fill such newly created vacancies, in each case, effective April 29, 2026.
Appointed

Paul Adams

Director
IACQ · Irenic Acquisition Corp.
Effective
2026-04-27
Filed
April 29, 2026, 7:59 PM ET
Paul Adams, Kirk S. Hachigian and Larry A. Lawson were appointed to the board of directors of the Company (the “Board”).
Appointed

Larry A. Lawson

Director
IACQ · Irenic Acquisition Corp.
Effective
2026-04-27
Filed
April 29, 2026, 7:59 PM ET
Paul Adams, Kirk S. Hachigian and Larry A. Lawson were appointed to the board of directors of the Company (the “Board”).
Appointed

Kirk S. Hachigian

Director
IACQ · Irenic Acquisition Corp.
Effective
2026-04-27
Filed
April 29, 2026, 7:59 PM ET
Paul Adams, Kirk S. Hachigian and Larry A. Lawson were appointed to the board of directors of the Company (the “Board”).
Departed

Robert L. Edwards, Jr.

Director
FWRD · FORWARD AIR CORP
Effective
2026-06-17
Filed
April 29, 2026, 7:59 PM ET
On April 24, 2026, the board of directors (the “Board”) of Forward Air Corporation (the “Company”) received notice from Charles L. Anderson and Robert L. Edwards, Jr. that each will not be standing for re-election at the Company’s annual meeting of stockholders to be held on June 17, 2026 (the “2026 Annual Meeting”).
Departed

Charles L. Anderson

Director
FWRD · FORWARD AIR CORP
Effective
2026-06-17
Filed
April 29, 2026, 7:59 PM ET
On April 24, 2026, the board of directors (the “Board”) of Forward Air Corporation (the “Company”) received notice from Charles L. Anderson and Robert L. Edwards, Jr. that each will not be standing for re-election at the Company’s annual meeting of stockholders to be held on June 17, 2026 (the “2026 Annual Meeting”).
Appointed

Leonardo Contreras Lerdo de Tejada

Chief Executive Officer
SCCO · SOUTHERN COPPER CORP/
Effective
2026-04-23
Filed
April 29, 2026, 7:59 PM ET
On April 23, 2026, the Company’s Board of Directors appointed Mr. Leonardo Contreras Lerdo de Tejada as Chief Executive Officer of the Company.
Departed

Oscar Gonzalez Rocha

President, Chief Executive Officer, and Board member
SCCO · SOUTHERN COPPER CORP/
Effective
2026-04-13
Successor
Leonardo Contreras Lerdo de Tejada
Filed
April 29, 2026, 7:59 PM ET
On April 13, 2026, Southern Copper Corporation (the "Company") announced with deep regret the unexpected passing of Oscar Gonzalez Rocha, the Company’s President, Chief Executive Officer, and Board member.
Departed

William R. Jellison

Class I member of the Board of Directors
ANIK · Anika Therapeutics, Inc.
Filed
April 29, 2026, 7:59 PM ET
On April 24, 2026, both William R. Jellison, a Class I member of the Board of Directors (the "Board") of the Company, and Glenn R. Larsen, Ph.D., a Class II member of the Board, notified the Board of their resignation from the Board, including from all committees on which each serves effective as of the Company's 2026 annual meeting of stockholders (the "2026 Annual Meeting").
Departed

Glenn R. Larsen

Class II member of the Board
ANIK · Anika Therapeutics, Inc.
Filed
April 29, 2026, 7:59 PM ET
On April 24, 2026, both William R. Jellison, a Class I member of the Board of Directors (the "Board") of the Company, and Glenn R. Larsen, Ph.D., a Class II member of the Board, notified the Board of their resignation from the Board, including from all committees on which each serves effective as of the Company's 2026 annual meeting of stockholders (the "2026 Annual Meeting").
Appointed

Marc James

Class II Director
SLSN · SOLESENCE, INC.
Effective
2026-04-24
Filed
April 29, 2026, 7:59 PM ET
Effective April 24, 2026, the Board of Directors of the Company (the "Board") appointed Marc James to serve as a Class II Director of the Board for the remainder of the term of Class II Directors of the Board, expiring at the 2026 Annual Meeting of Shareholders of the Company.
Appointed

Matthew K. Smith

Chief Executive Officer and President
FMBH · FIRST MID BANCSHARES, INC.
Effective
2026-07-01
Filed
April 29, 2026, 7:59 PM ET
Effective July 1, 2026, Matthew K. Smith will become Chief Executive Officer and President of the Company and its subsidiary, First Mid Bank & Trust, N.A., and will be appointed to the Company’s Board of Directors (the “Board”).
Role change

Joseph R. Dively

Executive Chair
FMBH · FIRST MID BANCSHARES, INC.
Effective
2026-07-01
Successor
Matthew K. Smith
Filed
April 29, 2026, 7:59 PM ET
In connection with the succession plan, Joseph R. Dively will transition from Chief Executive Officer to Executive Chair of the Company and remain Chairman of the Board.
Appointed

Pedro J. Beltran

Member of the Board of Directors
BBOT · BridgeBio Oncology Therapeutics, Inc.
Effective
2026-04-20
Filed
April 29, 2026, 7:59 PM ET
Eli Wallace, Ph.D. resigned from his position as a member of the Company’s Board of Directors and as a Class III director, and was succeeded by Pedro J. Beltran, Ph.D. in these positions and as the Company’s President and Chief Executive Officer, effective on April 20, 2026.
Departed

Eli Wallace

President and Chief Executive Officer
BBOT · BridgeBio Oncology Therapeutics, Inc.
Effective
2026-04-20
Successor
Pedro J. Beltran
Filed
April 29, 2026, 7:59 PM ET
Eli Wallace, Ph.D. resigned from his position as a member of the Company’s Board of Directors and as a Class III director, and was succeeded by Pedro J. Beltran, Ph.D. in these positions and as the Company’s President and Chief Executive Officer, effective on April 20, 2026.
Appointed

Pedro J. Beltran

President and Chief Executive Officer
BBOT · BridgeBio Oncology Therapeutics, Inc.
Effective
2026-04-20
Filed
April 29, 2026, 7:59 PM ET
Eli Wallace, Ph.D. resigned from his position as a member of the Company’s Board of Directors and as a Class III director, and was succeeded by Pedro J. Beltran, Ph.D. in these positions and as the Company’s President and Chief Executive Officer, effective on April 20, 2026.
Departed

Eli Wallace

Member of the Board of Directors
BBOT · BridgeBio Oncology Therapeutics, Inc.
Effective
2026-04-20
Successor
Pedro J. Beltran
Filed
April 29, 2026, 7:59 PM ET
Eli Wallace, Ph.D. resigned from his position as a member of the Company’s Board of Directors and as a Class III director, and was succeeded by Pedro J. Beltran, Ph.D. in these positions and as the Company’s President and Chief Executive Officer, effective on April 20, 2026.
Appointed

Martin Babler

Class I Director
MPLT · MapLight Therapeutics, Inc.
Effective
2026-06-23
Filed
April 29, 2026, 7:59 PM ET
The Board has nominated Martin Babler and Troy Cox as Class I director nominees to replace Dr. Malenka and Dr. Trenkle.
Departed

Jim Trenkle

Director
MPLT · MapLight Therapeutics, Inc.
Effective
2026-06-23
Successor
Martin Babler and Troy Cox
Filed
April 29, 2026, 7:59 PM ET
On April 23, 2026, Robert Malenka, M.D., Ph.D., and Jim Trenkle, Ph.D., notified the Board of Directors (the "Board") of MapLight Therapeutics, Inc. (the "Company") of their respective decisions not to stand for reelection at the Company’s Annual Meeting of Stockholders to be held on June 23, 2026.
Appointed

Troy Cox

Class I Director
MPLT · MapLight Therapeutics, Inc.
Effective
2026-06-23
Filed
April 29, 2026, 7:59 PM ET
The Board has nominated Martin Babler and Troy Cox as Class I director nominees to replace Dr. Malenka and Dr. Trenkle.
Departed

Robert Malenka

Director
MPLT · MapLight Therapeutics, Inc.
Effective
2026-06-23
Successor
Martin Babler and Troy Cox
Filed
April 29, 2026, 7:59 PM ET
On April 23, 2026, Robert Malenka, M.D., Ph.D., and Jim Trenkle, Ph.D., notified the Board of Directors (the "Board") of MapLight Therapeutics, Inc. (the "Company") of their respective decisions not to stand for reelection at the Company’s Annual Meeting of Stockholders to be held on June 23, 2026.
Appointed

Prakash Raman

Class II director
OLMA · Olema Pharmaceuticals, Inc.
Effective
2026-04-28
Filed
April 29, 2026, 7:59 PM ET
the Board appointed Dr. Prakash Raman to the Board as a Class II director, effective April 28, 2026
Role change

John Allen

Interim Chief Financial officer
RMBS · RAMBUS INC
Effective
2026-04-29
Successor
Sumeet Gagneja
Filed
April 29, 2026, 7:59 PM ET
In connection with the appointment, John Allen will cease serving as the Company’s Interim Chief Financial officer, effective as of the same date, and will continue to serve as the Company’s Vice President, Accounting and Chief Accounting Officer.
Appointed

Sumeet Gagneja

Senior Vice President and Chief Financial Officer
RMBS · RAMBUS INC
Effective
2026-04-29
Filed
April 29, 2026, 7:59 PM ET
The Board of Directors (the “Board”) of Rambus Inc. (“Rambus” or the “Company”) has appointed Sumeet Gagneja as the Senior Vice President and Chief Financial Officer of the Company, effective April 29, 2026, reporting to Luc Seraphin, Chief Executive Officer of the Company.
Appointed

William Sherman

Director
CXII · Churchill Capital Corp XII
Effective
2026-04-28
Filed
April 29, 2026, 7:59 PM ET
On April 27, 2026, in connection with the IPO, William Sherman was appointed to the board of directors of the Company (the “ Board ”) effective April 28, 2026.
Departed

Sam Eaton

Chief Technology Officer
YELP · YELP INC
Effective
2026-06-30
Successor
Alex Levy
Filed
April 29, 2026, 7:59 PM ET
Sam Eaton notified Yelp Inc. (the “Company”) of his decision to step down from his position as Chief Technology Officer, effective June 30, 2026
Departed

Arturo Rodriguez

Chief Executive Officer
ATER · Aterian, Inc.
Successor
David E. Lazar
Filed
April 29, 2026, 7:59 PM ET
Lazar will succeed Arturo Rodriguez
Appointed

David E. Lazar

Director
ATER · Aterian, Inc.
Effective
2026-04-29
Filed
April 29, 2026, 7:59 PM ET
the Board increased the authorized number of directors to five and appointed Lazar to the Board to fill the vacancy created by such increase, effective immediately
Appointed

David E. Lazar

Chief Executive Officer
ATER · Aterian, Inc.
Filed
April 29, 2026, 7:59 PM ET
the Board agreed to appoint Lazar as the sole Chief Executive Officer of the Company promptly following the Second SPA Closing
Departed

Bharat Vasan

Director
STCB · Starco Brands, Inc.
Effective
2026-04-27
Filed
April 29, 2026, 7:59 PM ET
Bharat Vasan notified the Board of Directors of Starco Brands, Inc. (the “Company”), that he resigns from the Board of Directors, effective April 27, 2026.
Appointed (interim)

Keshav Lall

interim Chief Executive Officer
FATAQ · Fat Brands, Inc
Effective
2026-04-29
Filed
April 29, 2026, 7:59 PM ET
Effective April 29, 2026, the Company and TWNP each appointed Keshav Lall as its interim Chief Executive Officer, filling in for the former Chief Executive Officer who remains on a leave of absence pursuant to the Amended and Restated Stipulation and Agreed Order Regarding Mediated Agreement [Docket No. 472].
Departed

Neeraj Agrawal

Director
CXM · Sprinklr, Inc.
Filed
April 29, 2026, 7:59 PM ET
On April 23, 2026, Neeraj Agrawal notified the Board that he will not stand for re-election as a Class II director of the Company at the 2026 Annual Meeting.
Departed

Yvette Kanouff

Director
CXM · Sprinklr, Inc.
Filed
April 29, 2026, 7:59 PM ET
On April 23, 2026, Yvette Kanouff notified the board of directors (the “Board”) of Sprinklr, Inc. (the “Company”) that she will not stand for re-election as a Class II director of the Company at the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”).
Departed

Diane Bryant

Director
J · JACOBS SOLUTIONS INC.
Effective
2026-04-26
Filed
April 29, 2026, 7:59 PM ET
On April 26, 2026, Diane Bryant resigned as a member of the Board of Directors of Jacobs Solutions Inc. (the “Company”).
Departed

Jodi Devlin

Chief of Clinical Operations
TLSI · TriSalus Life Sciences, Inc.
Effective
2026-10-01
Filed
April 29, 2026, 7:59 PM ET
On April 24, 2026, Jodi Devlin provided notice to TriSalus Life Sciences, Inc. (the “Company”) of her intention to retire from her role as Chief of Clinical Operations, effective October 1, 2026.
Appointed

Dr. Richard Marshall

Chief Medical Officer
TLSI · TriSalus Life Sciences, Inc.
Effective
2026-06-29
Filed
April 29, 2026, 7:59 PM ET
As previously announced on April 7, 2026, the Company appointed Dr. Richard Marshall to Chief Medical Officer of the Company, effective June 29, 2026.
Departed

Elda de la Peña

Chief Administrative Officer and Chief Human Resources Officer
Tri-State Generation & Transmission Association, Inc.
Effective
2026-12-01
Filed
April 29, 2026, 7:59 PM ET
On April 27, 2026, Tri-State Generation and Transmission Association, Inc. (“Tri-State”) received notice from its Chief Administrative Officer and Chief Human Resources Officer, Elda de la Peña, that she intends to retire in December 2026 after more than 29 years of service with Tri-State.
Departed

Diane Schnupp

Executive Vice President and Chief Information Officer
KNSL · Kinsale Capital Group, Inc.
Effective
2026-04-29
Filed
April 29, 2026, 7:59 PM ET
On April 29, 2026, Diane Schnupp, Executive Vice President and Chief Information Officer of Kinsale Capital Group, Inc. (the “Company”), notified the Company of her intent to retire from the Company.
Appointed

Mark Thornton

Director
XPEL · XPEL, Inc.
Effective
2026-04-23
Filed
April 29, 2026, 7:59 PM ET
On April 23, 2026, the Board of Directors of XPEL, Inc. (the “Company) appointed Mark Thornton to the Board of Directors of the Company.
Appointed

Lindsey Wiedmann

Chief Legal and Compliance Officer
NXT · Nextpower Inc.
Effective
2026-07-17
Filed
April 29, 2026, 7:59 PM ET
On April 28, 2026, the Board of Directors approved the appointment of Lindsey Wiedmann as Chief Legal and Compliance Officer, effective upon Mr. Ledesma’s retirement.
Departed

Bruce Ledesma

Chief Legal and Compliance Officer
NXT · Nextpower Inc.
Effective
2026-07-17
Successor
Lindsey Wiedmann
Filed
April 29, 2026, 7:59 PM ET
On April 23, 2026, Bruce Ledesma, the Chief Legal and Compliance Officer of Nextpower Inc. (the “Company”) informed the Company that he will retire effective July 17, 2026.
Appointed

Steven A. Brandjord

Corporate Controller and Chief Accounting Officer
CBSH · COMMERCE BANCSHARES INC /MO/
Effective
2026-05-15
Filed
April 28, 2026, 7:59 PM ET
The Board of Directors of Commerce Bancshares, Inc. (“Company”) approved the Company's appointment of Steven A. Brandjord in the role of Corporate Controller and Chief Accounting Officer, effective May 15, 2026.
Departed

F. Brooks Bertsch

Director
FLXS · FLEXSTEEL INDUSTRIES INC
Effective
2026-04-28
Filed
April 28, 2026, 7:59 PM ET
F. Brooks Bertsch resigned from the Board pursuant to the terms of the Stock Repurchase Agreement.
Role change

De'Mon L. Wiggins

Executive Vice President and President, Flow, Water Solutions and Pool
PNR · PENTAIR plc
Effective
2026-04-28
Filed
April 28, 2026, 7:59 PM ET
the Company also announced that it appointed De’Mon L. Wiggins, the current Executive Vice President and President, Flow and Water Solutions of the Company, as the Company’s Executive Vice President and President, Flow, Water Solutions and Pool, effective as of April 28, 2026.
Departed

Jerome O. Pedretti

Executive Vice President and Chief Executive Officer, Pool
PNR · PENTAIR plc
Effective
2026-07-01
Filed
April 28, 2026, 7:59 PM ET
Jerome O. Pedretti, the Executive Vice President and Chief Executive Officer, Pool of Pentair plc (the “Company”), elected to resign from the Company effective as of July 1, 2026.
Appointed

Jamie A. Beggs

Senior Vice President and Chief Financial Officer
PPG · PPG INDUSTRIES INC
Effective
2026-07-06
Successor
Vincent J. Morales
Filed
April 28, 2026, 7:59 PM ET
On April 28, 2026, PPG Industries, Inc. (the “Company”) issued a press release announcing that Jamie A. Beggs will join the Company as Senior Vice President and Chief Financial Officer, effective July 6, 2026 upon the previously reported retirement of Vincent J. Morales which will also be effective July 6, 2026.
Departed

Vincent J. Morales

Senior Vice President and Chief Financial Officer
PPG · PPG INDUSTRIES INC
Effective
2026-07-06
Successor
Jamie A. Beggs
Filed
April 28, 2026, 7:59 PM ET
On April 28, 2026, PPG Industries, Inc. (the “Company”) issued a press release announcing that Jamie A. Beggs will join the Company as Senior Vice President and Chief Financial Officer, effective July 6, 2026 upon the previously reported retirement of Vincent J. Morales which will also be effective July 6, 2026.
Departed

Marianna Tessel

Executive Vice President and General Manager, Small Business Group
INTU · INTUIT INC.
Effective
2026-05-31
Successor
Ashley Still
Filed
April 28, 2026, 7:59 PM ET
Marianna Tessel will step down from her role as Executive Vice President and General Manager, Small Business Group, effective May 31, 2026.
Role change

Ashley Still

Executive Vice President and General Manager, Mid-Market Group
INTU · INTUIT INC.
Effective
2026-05-31
Filed
April 28, 2026, 7:59 PM ET
Ashley Still, Executive Vice President and General Manager, Mid-Market Group, will expand her role to lead both the Mid-Market Group and the Small Business Group.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.